That's a great question, Olof, and these two metrics offer valuable insights into market expectations for Recursion Pharmaceuticals (RXRX).
Understanding Market Expectations for RXRX
- Implied Volatility (IV) of 62.80%: This figure suggests that the options market anticipates significant price movement for RXRX in the near future. A 62.80% implied volatility is quite high, indicating that options traders are pricing in a substantial degree of uncertainty and potential for large swings in the stock's price, either up or down. This often occurs around major events such as earnings announcements, clinical trial results, or other company-specific news that could materially impact its valuation.
- Put/Call Open Interest (OI) Ratio of 0.42: The Put/Call OI Ratio is calculated by dividing the total number of open put options by the total number of open call options. Fintel's data for RXRX shows a Put/Call Ratio of 0.43.1 Since puts are generally used for bearish bets and calls for bullish bets, a ratio significantly below 1.0, like 0.42 or 0.43, indicates a predominantly bullish sentiment among options traders. It suggests that there is considerably more open interest in call options than in put options, implying that a larger number of options participants are positioned for an upward move in RXRX's stock price.
In summary, the market for RXRX options is currently characterized by expectations of large price movements (high implied volatility) and a clear directional bias towards the upside (low put/call OI ratio). This combination can suggest that while traders expect a significant move, the consensus among options participants leans bullish. Further analysis of Fintel's options data, including specific options flow and gamma exposure, could provide deeper context into these market expectations.1
